Variables | Univariable analysis | Multivariable analysis | ||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Treatment regimen | ||||
 FFX vs AG | 1.193 (0.589–2.523) | 0.621 |  |  |
Age (years) | ||||
  ≥ 60 vs < 60 | 0.742 (0.365–1.511) | 0.411 |  |  |
Gender | ||||
 Male vs female | 0.999 (0.465–2.146) | 0.997 |  |  |
Baseline CA19-9, U/mL | ||||
 Elevated (> 37) vs normal | 0.976 (0.449–2.121) | 0.951 |  |  |
Baseline CEA, ng/mL | ||||
 Elevated (> 7.2) vs normal | 0.731 (0.363–1.473) | 0.381 |  |  |
Tumor site of pancreas | ||||
 Head/neck vs body/tail | 0.724 (0.354–1.479) | 0.375 |  |  |
Number of metastasis | ||||
  ≥ 2 vs 1 | 1.672 (0.818–3.416) | 0.158 |  |  |
Liver metastasis | ||||
 Yes vs no | 1.857 (0.844–4.085) | 0.124 |  |  |
Combined with radiotherapy | ||||
 Yes vs no | 0.697 (0.347–1.401) | 0.311 |  |  |
PNI (prognostic nutrition index) | ||||
  < 43.7 vs ≥ 43.7 | 2.310 (1.098–4.858) | 0.027* | 2.252 (1.021–4.959) | 0.044* |